Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
- 11,12-EET cPLA2i 1.0 BCD110605C16 0.283 pmol/ml of medium
- 11,12-EET cPLA2i 1.0 BCD110605C18 0.287 pmol/ml of medium
- 11,12-EET cPLA2i 1.0 BCD110605C17 0.268 pmol/ml of medium
- 11,12-EET cPLA2i 4.0 BCD110605C34 0.349 pmol/ml of medium
- 11,12-EET cPLA2i 4.0 BCD110605C36 0.415 pmol/ml of medium
- 11,12-EET cPLA2i 4.0 BCD110605C35 0.24 pmol/ml of medium
- 11,12-EET cPLA2i 20.0 BCD110605C53 0.142 pmol/ml of medium
- 11,12-EET cPLA2i 20.0 BCD110605C54 0.169 pmol/ml of medium
- 11,12-EET cPLA2i 20.0 BCD110605C52 0.166 pmol/ml of medium
- 11,12-EET PLDi 1.0 BCD110605C10 0.254 pmol/ml of medium
- 11,12-EET PLDi 1.0 BCD110605C12 0.257 pmol/ml of medium
- 11,12-EET PLDi 1.0 BCD110605C11 0.347 pmol/ml of medium
- 11,12-EET PLDi 4.0 BCD110605C30 0.257 pmol/ml of medium
- 11,12-EET PLDi 4.0 BCD110605C29 0.336 pmol/ml of medium
- 11,12-EET PLDi 4.0 BCD110605C28 0.407 pmol/ml of medium
- 11,12-EET PLDi 20.0 BCD110605C48 0.14 pmol/ml of medium
- 11,12-EET PLDi 20.0 BCD110605C47 0.134 pmol/ml of medium
- 11,12-EET PLDi 20.0 BCD110605C46 0.181 pmol/ml of medium
- 11,12-EET KDO+cPLA2i 1.0 BCD110605C19 0.388 pmol/ml of medium
- 11,12-EET KDO+cPLA2i 1.0 BCD110605C21 0.314 pmol/ml of medium
- 11,12-EET KDO+cPLA2i 1.0 BCD110605C20 0.259 pmol/ml of medium
- 11,12-EET KDO+cPLA2i 4.0 BCD110605C39 0.777 pmol/ml of medium
- 11,12-EET KDO+cPLA2i 4.0 BCD110605C37 0.751 pmol/ml of medium
- 11,12-EET KDO+cPLA2i 4.0 BCD110605C38 0.861 pmol/ml of medium
- 11,12-EET KDO+cPLA2i 20.0 BCD110605C55 0.588 pmol/ml of medium
- 11,12-EET KDO+cPLA2i 20.0 BCD110605C57 0.653 pmol/ml of medium
- 11,12-EET KDO+cPLA2i 20.0 BCD110605C56 0.616 pmol/ml of medium
- 11,12-EET KDO+PLDi 1.0 BCD110605C15 0.33 pmol/ml of medium
- 11,12-EET KDO+PLDi 1.0 BCD110605C14 0.352 pmol/ml of medium
- 11,12-EET KDO+PLDi 1.0 BCD110605C13 0.307 pmol/ml of medium
- 11,12-EET KDO+PLDi 4.0 BCD110605C32 0.813 pmol/ml of medium
- 11,12-EET KDO+PLDi 4.0 BCD110605C31 0.805 pmol/ml of medium
- 11,12-EET KDO+PLDi 4.0 BCD110605C33 0.802 pmol/ml of medium
- 11,12-EET KDO+PLDi 20.0 BCD110605C49 0.684 pmol/ml of medium
- 11,12-EET KDO+PLDi 20.0 BCD110605C51 0.964 pmol/ml of medium
- 11,12-EET KDO+PLDi 20.0 BCD110605C50 0.593 pmol/ml of medium
- 11,12-EET KDO + ATP 1.0 BCD110605C07 0.345 pmol/ml of medium
- 11,12-EET KDO + ATP 1.0 BCD110605C09 0.434 pmol/ml of medium
- 11,12-EET KDO + ATP 1.0 BCD110605C08 0.407 pmol/ml of medium
- 11,12-EET KDO + ATP 4.0 BCD110605C25 1.19 pmol/ml of medium
- 11,12-EET KDO + ATP 4.0 BCD110605C26 0.943 pmol/ml of medium
- 11,12-EET KDO + ATP 4.0 BCD110605C27 0.793 pmol/ml of medium
- 11,12-EET KDO + ATP 20.0 BCD110605C45 0.845 pmol/ml of medium
- 11,12-EET KDO + ATP 20.0 BCD110605C43 0.661 pmol/ml of medium
- 11,12-EET KDO + ATP 20.0 BCD110605C44 1.06 pmol/ml of medium
- 11,12-EET C 0.0 BCD110605C02 0.189 pmol/ml of medium
- 11,12-EET C 0.0 BCD110605C01 0.23 pmol/ml of medium
- 11,12-EET C 0.0 BCD110605C03 0.296 pmol/ml of medium
- 11,12-EET C 1.0 BCD110605C06 0.249 pmol/ml of medium
- 11,12-EET C 1.0 BCD110605C05 0.269 pmol/ml of medium